Study: Elevated THC Blood Levels Persist for Days in Habitual Cannabis Consumers

By Paul Armentano, NORML

VICTORIA, AUSTRALIAblood — The presence of THC may persist in the blood of habitual cannabis consumers for multiple days at concentrations above 5ng/ml, according clinical data recently published in the journal Forensic Science International.

Australian researchers assessed daily concentrations of THC in the blood of 21 subjects over a period of 7 days of monitored abstinence. Subjects reported having engaging in the “heavy” use of cannabis during the months leading up to the study.

Read moreStudy: Elevated THC Blood Levels Persist for Days in Habitual Cannabis Consumers

Poll: More Than Six In Ten Connecticut Voters Say Legalize Cannabis

By Paul Armentano, NORML

More thanusepicture six out of ten Connecticut voters favor legalizing marijuana use by adults, according to statewide polling conducted by Quinnipiac University.

Sixty-three percent of respondents said that they favored permitting adults to legally possess personal use quantities of cannabis. Only 34 percent of voters opposed this idea.

Read morePoll: More Than Six In Ten Connecticut Voters Say Legalize Cannabis

Daily, Long-Term Cannabis Use Not Associated with Adverse Changes in Lung Health

By Paul Armentano, NORML

Study Finds That Long Term Cannabis Exposure “Not Associated With Significant Effects On Lung Function”

ATLANTA, GA — The inhalationLos Angeles City Council Votes To Ban Medical Marijuana Dispensaries of one marijuana cigarette per day over a 20-year period is not associated with adverse changes in lung health, according to data published online ahead of print in the journal Annals of the American Thoracic Society.

Investigators at Emory University in Atlanta assessed marijuana smoke exposure and lung health in a large representative sample of US adults age 18 to 59. Researchers reported that cannabis exposure was not associated with FEV1 (forced expiratory volume) decline or deleterious change in spirometric values of small airways disease.

Read moreDaily, Long-Term Cannabis Use Not Associated with Adverse Changes in Lung Health

Study: No Longitudinal Association Between Cannabis Use and Depression

By Paul Armentano, NORML

TEL AVIV, ISRAEL — Cannabis use is not associated joint with increased incidences of major depression, according to longitudinal data published online ahead of print in the Journal of Affective Disorders.

An international team of investigators from Israel and Canada assessed the association between cannabis use, major depressive disorder (MDD) and bipolar disorder (BP) in a three-year prospective study.

Authors determined that future incidence of MDD was not higher among cannabis users compared to nonusers. They reported: “Our results show no significant association between cannabis use and the incidence of major depression.

Read moreStudy: No Longitudinal Association Between Cannabis Use and Depression

Study: Evidence Fails to Support DUI Impairment Levels for Cannabis

By Paul Armentano, NORML

WASHINGTON, DC — Available science fails to support the imposition of driving under thedriving influence (DUI) impairment thresholds for cannabis in a manner that is analogous to the per se limits already in place for alcohol, according to the conclusions of a November 2014 publication published by the United States Department of Transportation, National Highway Traffic Safety Administration (NHTSA). Per se traffic safety laws criminalize those who operate a vehicle with trace or specific levels of a controlled substance in their bodily fluids, even in the absence of any further evidence indicating that the subject was behaviorally impaired.

Read moreStudy: Evidence Fails to Support DUI Impairment Levels for Cannabis

Federal Judge to Hold Hearing on Whether Cannabis Should be Removed as a Schedule 1 Drug

By Paul Armentano, NORML

Testimony regarding the constitutionality of the federal statute gavelbuddesignating marijuana as a Schedule I Controlled Substance will be taken on Monday, October 27 in the United States District Court for the Eastern District of California in the case of United States v. Pickard, et. al., No. 2:11-CR-0449-KJM.

Members of Congress initially categorized cannabis as a Schedule I substance, the most restrictive classification available, in 1970. Under this categorization, the plant is defined as possessing “a high potential for abuse, … no currently accepted medical use in treatment in the United States, … [and lacking] accepted safety for … use … under medical supervision.”

New Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients

By Paul Armentano, NORML

The administration of a single dose of whole-plant cannabis via a thermal-meteredcannabisisnotpot inhaler is effective and well tolerated among patients suffering from neuropathy (nerve pain), according to clinical trial data published online ahead of print in the Journal of Pain and Palliative Care Pharmacotherapy.

Israeli investigators assessed the efficacy of a novel, portable metered-dose cannabis inhaler in eight subjects diagnosed with chronic neuropathic pain. Researchers reported that the device administered an efficient, consistent, and therapeutically effective dosage of cannabinoids to all participants.

Read moreNew Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients

New Study: Medical Marijuana Legalization Not Associated With Increased Use By Adolescents

By Paul Armentano, NORML Deputy Director

The enactment of state laws legalizing the physician-recommended use of cannabis therapy is not associated with increased levels of marijuana use by young peoplenormlbud, according to data published online in the Journal of Adolescent Health.

Researchers at Rhode Island Hospital and Brown University assessed the impact of medical cannabis laws by examining trends in reported drug use by high-schoolers in a cohort of states before and after legalization. Researchers compared these trends to geographically matched states that had not adopted medical marijuana laws.

Read moreNew Study: Medical Marijuana Legalization Not Associated With Increased Use By Adolescents

Growing Majority of Americans Support Cannabis Legalization

By Paul Armentano, Deputy Director, NORML 

Fifty-five percent of Americans favor making cannabis legal for adults, according to the findings ofcannaamerica a CNN/ORC International survey released late Monday. The percentage is the highest ever reported by the survey, which has been tracking public opinion on the issue since 1973, and marks a 12 percentage point jump in support since the last time pollsters posed the question in 2012.

In addition, only 35 percent of those polled responded that consuming cannabis was “morally wrong” — down from 70 percent in 1987, the last time pollsters posed the question.

Read moreGrowing Majority of Americans Support Cannabis Legalization